StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 9/30/2014, (NASDAQ:SLXP), $156.4 +0.62, +0.40%, "SELL" Salix Pharmaceuti Stock
 




  
  

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   9/30/2014   StockRing.com recommends to   "SELL"   SLXP   stock at current price of   $156.4.
Today SLXP stock opened at $156.72 and was trading in the daily range of $ 156.00 - 157.18 per share.
Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $9.961B. SLXP average daily volume is 1,610,990.
On last trading session SLXP stock traded 36,569 shares. Also the Short Ratio for (NASDAQ:SLXP) stock is 5.70.
Last year Salix Pharmaceuti(NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $454.5M on revenue of $1.262B.
SLXP 50-Day Moving Average is $153.42 vs. $156.4 now and 200-Day Moving Average is $125.93 vs. $156.4.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "HOLD".  S&P 500 is "HOLD" on  5/16/2014
--------------------------------------------------------------------------------------------------------------------
SLXP Earnings Per Share - EPS (ttm) is 0.9. SLXP Stock Price Per Earnings ratio - P/E is 172.51.
Salix Pharmaceuti(NASDAQ:SLXP) stock pays a dividend of $0.00 per share which is a yield of N/A%.
On average analysts predict that One Year Target Estimated price for SLXP stock is $164.59.
In the last 52 weeks SLXP stock was trading in the range of $66.67 - 172.98.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

BUY  DOW 30+: FF  FTK  PTEN  NR  EXH     ENERGY: ADMA  RNG  CDW  CBA  BLUE     HEALTH: ACWX  EPHE  FM  DVYA  AOM 
      FINANCE: XLK  DWX  BWZ  GII  SCPB     SERVICES: UST  MLPX  BRAQ  YCL  EMFM     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: PVA  PWE  FOE  GNE  EOX     ENERGY: RMAX  SEAS  NBCB  PETX  VOYA     HEALTH: ITA  ICLN  EIRL  SCZ  PICK 
      FINANCE: XME  XSW  KBE  EWO  BAL     SERVICES: VIXM  EEV  UVXY  QID  AGQ     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



9/30/2014  Tuesday, September 30, 2014 (Irvine, California) Today StockRing.com Recommendation is to "SELL"for Salix Pharmaceuti (NASDAQ:SLXP) Stock. SLXP stock opening price was $156.72 per share. Current price of NASDAQ:SLXP Stock is $156.4 per share and it is $+0.62, (+0.40%) today and it was trading in the daily range of $156.00 - 157.18 per share. Current Bid Price for (NASDAQ:SLXP) stock is $156.35 and the Ask Price is $156.45. In the last 52 weeks SLXP stock was trading in the range of $66.67 - 172.98. 50-Day Moving Average for (NASDAQ:SLXP) stock is $153.42 and 200-Day Moving Average is $125.93. On average analysts predict that One Year Target Estimated price for (NASDAQ:SLXP) stock is $164.59.

Salix Pharmaceuti (NASDAQ:SLXP) is rated as a sell on 9/10/2014 1:26:20 AM.

Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $9.961B. (NASDAQ:SLXP) stock average daily volume is 1,610,990 shares per day. However, on last trading session of 9:33am, 2012 SLXP stock traded 36,569 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:SLXP) stock is 5.70. On previous trading session SLXP Stock closed at $155.78 per share.

Last year Salix Pharmaceuti (NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $454.5M on total revenue of $1.262B. Earnings Per Share - EPS (ttm) for SLXP stock is 0.9. Also, (NASDAQ:SLXP) Stock Price Per Earnings ratio - P/E is 172.51. Thus, (NASDAQ:SLXP) Stock Price/Sales (ttm) ratio is 7.86 and Price/Book (mrq) ratio is 13.44.

(NASDAQ:SLXP) Stock does NOT PAY any dividend. So at this time (NASDAQ:SLXP) Stock maintains Trailing Annual Dividend Rate at 0.00 .


StockRing Recommendations for Salix Pharmaceuti (NASDAQ:SLXP) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=SLXP

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

9/30/2014 1 Year Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, September 30, 2014
  
1 Year SLXP 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
9/30/2014 5 days Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, September 30, 2014
  
5 Days SLXP 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

9/30/2014 Stock market price quote data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, September 30, 2014

Last Trade: 156.4
Trade Time: 9:33am
Change: +0.62, (+0.40%)
Prev Close: 155.78
Open: 156.72
Bid: 156.35
Ask: 156.45
1y Target Est: $164.59
50-Day Moving Average: 153.42
200-Day Moving Average:
125.93
Short Ratio: 5.70
Trailing Annual Dividend Rate: 0.00
Day's Range: 156.00 - 157.18
52wk Range: 66.67 - 172.98
Volume: 36,569
Avg Vol: 1,610,990
Market Cap: 9.961B
P/E (ttm): 172.51
EPS (ttm): 0.9
Div & Yield: 0.00 (N/A%)
Revenue (ttm): 1.262B
Earnings before Tax (EBITDA) (ttm): 454.5M
Price/Sales (ttm): 7.86
Price/Book (mrq): 13.44
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs



9/30/2014 Latest stock market news data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, September 30, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Pharma Events To Watch Out For This Week
Bidness ETC - 21 hours ago
The week will start off with the US Food and Drug Administration's (FDA) decision on Salix Pharmaceuticals, Ltd.
FDA approves expanded use of Salix Pharma's constipation drug - Yahoo News
Jackson Square Teams Up With T. Rowe And Pentwater Against Allergan-Salix ...
Bidness ETC - Sep 29, 2014
... T. Rowe Price Group Inc. (TROW) and Pentwater Capital Management LP yesterday in voicing concerns over Allergan's lack of corporate governance and its impact on the company's shareholders regarding the Allergan-Salix Pharmaceuticals, Ltd. (SLXP) ...
Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix - Benzinga
Like a Mouse Cornered By A Cat, Allergan Fights The Future - ValueWalk
Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.
Benzinga - Sep 23, 2014
Allergan, Inc. (NYSE: AGN) is set to acquire Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) in a deal probably worth more than $10 billion, according to Dow Jones Newswires.
Allergan close to deal with Salix to fend off hostile takeover: report - Financial Post
Actavis in buyout talks with Salix: CNBC - Reuters
T. Rowe Unwelcoming Of Salix-Allergan Merger
Bidness ETC - Sep 27, 2014
The financial-services firm's statement is in light of Allergan's recent acquisition discussions with Salix Pharmaceuticals, Ltd. (SLXP), in an attempt to ward off Valeant's bid. The California-based drug maker believes the potential acquisition of ...
Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today
TheStreet.com - Sep 17, 2014
NEW YORK (TheStreet) -- Shares of Salix Pharmaceuticals Ltd. (SLXP) are up 1.37% to $158 in pre-market trade as some of the top 20 investors are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals, and are pressing Salix to ...
Top Salix shareholders not on board with Cosmo deal - Seeking Alpha (registration)
Exclusive: Top investors push Salix to abandon Cosmo deal - sources - Reuters
Credit Suisse Sees Downside In Shares Of Salix Pharmaceuticals, Ltd.
Benzinga - Sep 12, 2014
Analysts at Credit Suisse initiated coverage on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) with an Underperform rating and $139 price target Friday.
Salix Pharmaceuticals Receives New Coverage from Analysts at Credit Suisse ... - sleekmoney
Salix Signs Deal With Lupin
Bidness ETC - Sep 12, 2014
Salix Pharmaceuticals, Ltd. (SLXP) has entered into an agreement with India-based pharmaceutical Lupin Limited; granting the company commercialization rights for two of its gastrointestinal drugs, Zaxine and Relistor, in Canada.
Lupin To Market Salix Pharma Products In Canada - RTT News
Lupin in deal to market US firm Salix's drugs in Canada - Reuters
Salix Receives $100 Million In Patent Infringement Settlement
Bidness ETC - Sep 23, 2014
Salix Pharmaceuticals, Ltd. (SLXP) announced yesterday, that it has received $100 million in patent settlement from the generic drug maker Par Pharmaceutical Companies, Inc. (PRX).
Allergan-Valeant Soap Opera Continues
Bidness ETC - Sep 25, 2014
Actavis plc (ACT) is planning to acquire Salix Pharmaceuticals, Ltd. (SLXP), which has also been an acquisition target for Allergan, Inc. (AGN) for weeks, according to CNBC.
Shareholder T. Rowe Price urges Allergan to hold off on deals - Reuters
Allergan Shareholder T. Rowe Says No Deals Without Vote - Businessweek
Pharma Stocks in the News: Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP ...
Equities Focus (registration) - Sep 22, 2014
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) said its Santarus Pharmaceuticals unit and the University of Missouri have reached a settlement in a patent infringement case with Par Pharmaceutical.

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


9/30/2014 News from StockRing Blog about Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, September 30, 2014



Copyright © 2014 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds   Form

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.